Clinical Trials Sponsored by David A. Talan

Total 29 results

David A. Talan
Light AI, Inc.

Completed

Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal Pharyngitis

Group A Streptococcal Infection

United States
Eytan A. David

Active, not recruiting

Posturography-assisted Vestibular Retraining for Stable Unilateral Vestibular Deficit

Dizziness | Equilibrium; Disorder, Labyrinth | Inner Ear Injury | Inner Ear Disease

Canada
Eytan A. David

Completed

Interactive Rehabilitation for Adults With Unilateral Vestibular Weakness

Dizziness | Equilibrium; Disorder, Labyrinth | Inner Ear Injury

Canada
David A. Clump, MD, PhD

Completed

Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of the Head and Neck

United States
David A. Clump, MD, PhD

Completed

Surgery With or Without Adjuvant Stereotactic Body Radiotherapy

Head and Neck Cancer

United States
David A Berntsen, OD PhD

Completed

Contact Lens Optics and Visual Performance

Myopia

United States
David A. Clump, MD, PhD

Completed

SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma

Adenocarcinoma of the Pancreas

United States
David A Berntsen, OD PhD

Completed

Evaluating Contact Lens Optics

Myopia

United States
David A. Clump, MD, PhD

Completed

Low-Level Laser Therapy for Prevention of Oral Mucositis

Mucositis

United States
David A. Clump, MD, PhD

Completed

Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma

Pancreatic Cancer

United States
David A. Johnson, MD
AstraZeneca

Completed

Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance

GERD

United States
David A Katz
American Heart Association

Completed

Chest Pain Observation Unit Risk Reduction Trial

Chest Pain

United States
David Rizzieri, MD
Genzyme, a Sanofi Company; Celgene Corporation

Completed

Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Leukemia, Lymphocytic, Chronic, B-Cell

United States
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia (Osteosimply014)

Human Immunodeficiency Virus

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection (VIRECURE)

HIV Infections

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Not yet recruiting

Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial) (ELPIS)

Mammary Cancer

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Completed

Comparative Study of the Efficacy of Oral Versus Intravenous Hydration as a Preventive Measure of Contrast-induced Nephropathy (CIN) in Patients With Renal Insufficiency (RI) Grade III Under Study Conducting Computed Tomography (CT) (NICIR)

Renal Insufficiency

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM (RALAM-RollOver)

HIV Infections | HIV Seropositivity | HIV-1-infection

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen (RALAM-II)

HIV Infections | HIV Seropositivity | HIV-1-infection

Spain
David A Wohl, MD
Merck Sharp & Dohme LLC

Completed

Raltegravir as Early Therapy in African-Americans Living With HIV Study (REAL)

HIV Infections

United States
George A. Kaysen, M.D.
Beth Israel Medical Center

Terminated

The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients (ICM)

Hypoalbuminemia

United States
Peter Davis
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Dexmedetomidine as a Rapid Bolus in Children for Emergence Agitation

Tonsillectomy

United States
David Van Sickle
Foundation for a Healthy Kentucky; Norton Healthcare Foundation; Owsley Brown...

Completed

Asthma Data Innovation Demonstration Project (ADID)

Respiratory Tract Diseases | Immune System Diseases | Lung Diseases | Hypersensitivity | Hypersensitivity, Immediate | Bronchial Diseases | Lung Diseases, Obstructive | Asthma | Respiratory Hypersensitivity

United States
Michael A. Rogawski, MD, PhD
United States Department of Defense

Completed

Allopregnanolone for the Treatment of Traumatic Brain Injury

Traumatic Brain Injury | Posttraumatic Epilepsy

United States
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica; Miquel Ferrer - Investigator Coordinator

Unknown

Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response (2017-001406-15)

Community-acquired Pneumonia

Spain
Avazzia, Inc
University of Texas Southwestern Medical Center; Lawrence A. Lavery, DPM, MPH; Kathryn Davis, Ph.D...

Terminated

Avazzia-University of Texas Southwestern Medical Center-Tennant Biomodulator® PRO Perfusion Study

Wound; Foot | Perfusion; Complications

United States
Eva Prescott
Rigshospitalet, Denmark; University of Copenhagen; University of California,... and other collaborators

Completed

Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training (CUT-IT)

Obesity | Ischemic Heart Disease

Denmark
University of California, San Francisco
Albert Einstein Healthcare Network; National Cancer Institute (NCI); University... and other collaborators

Completed

CT DOSE Collaboratory

Quality Improvement | Ionizing Radiation Exposure
Sanford Health
National Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaborators

Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (CoRDS)

Mitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditions

United States, Australia

Clinical Trials Sponsored by David A. Talan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations